Downs Christopher S — SEC insider filings

SEC reporting owner CIK 1705978. 17 insider filings on record with FilingPulse; latest filed 2026-11-02.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2020-08-25 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CNS Pharmaceuticals, Inc. (CNSP)Chief Financial Officer136 legs · 248,266 sh · $363,670—11
EBET, Inc. (EBET)Director2——3
Vertical Data Inc. (VDTA)Interim CFO and Secretary2——3

Insider filings — Downs Christopher S

FiledFormIssuerReported transactionsSource
2026-11-024Vertical Data Inc. (VDTA)Grant/award (A): 1,270 @ $3.94EDGAR
2026-10-024Vertical Data Inc. (VDTA)Grant/award (A): 1,357 @ $3.68 · Grant/award (A): 891 @ $5.61EDGAR
2025-11-194CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 4,881 (derivative) @ $0EDGAR
2024-04-104CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 40,000 (derivative) · Grant/award (A): 40,000 (derivative)EDGAR
2024-02-064CNS Pharmaceuticals, Inc. (CNSP)Purchase (P): 66,666 @ $0.30 · Grant/award (A): 66,666 (derivative) · Grant/award (A): 66,666 (derivative)EDGAR
2023-08-234CNS Pharmaceuticals, Inc. (CNSP)Purchase (P): 27,000 @ $1.27EDGAR
2023-05-014CNS Pharmaceuticals, Inc. (CNSP)Option exercise (M): 521 · Option exercise (M): 521 (derivative)EDGAR
2023-04-184CNS Pharmaceuticals, Inc. (CNSP)Purchase (P): 3,100 @ $3.20EDGAR
2023-03-314CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 6,067 (derivative)EDGAR
2023-02-104EBET, Inc. (EBET)Option exercise (M): 6,300 · Option exercise (M): 6,300 (derivative)EDGAR
2022-04-294CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 250,000 (derivative)EDGAR
2022-03-144CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 33,000 @ $0.31EDGAR
2022-02-114Esports Technologies, Inc. (EBET)Grant/award (A): 6,300 (derivative)EDGAR
2021-12-074CNS Pharmaceuticals, Inc. (CNSP)Purchase (P): 5,000 @ $0.94EDGAR
2021-11-224CNS Pharmaceuticals, Inc. (CNSP)Purchase (P): 4,500 @ $1.15EDGAR
2021-02-094CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 131,000 (derivative)EDGAR
2020-08-254CNS Pharmaceuticals, Inc. (CNSP)Purchase (P): 142,000 @ $2.04EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1705978 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs